THE CONOLIDINE DIARIES

Our profiling and comparison from the steps of conolidine and cannabidiol with known pharmacological agents predicted a MOA shared with Cav2.two channel blocker, ω-conotoxin CVIE.Most recently, it has been determined that conolidine and the above mentioned derivatives act on the atypical chemokine receptor three (ACKR3. Expressed in very similar r

This is the summary overview of existing Cochrane Evaluations, we are not mindful of any overviews or critiques summarising non‐Cochrane evaluations.Reporting should contain median and selection and suggest and normal deviation (SD) of outcomes. This will permit viewers to review the consequences of any outliers that may have skewed the data, whi